Atossa Genetics Closes FDA Inspections - Quick Facts

(RTTNews) - Atossa Genetics Inc. (ATOS) said it has received "establishment inspection reports," or EIRs, from the U.S. Food and Drug Administration, Office of Compliance, regarding inspections conducted by the FDA in 2012 and 2014. Issuance of the EIRs means that the FDA has now closed those inspections.

Steven Quay, Chairman, CEO and President, stated, "Over the past 18 months, we have worked diligently to ensure that all observations noted during the inspections were being resolved expeditiously. I would like to thank the entire Atossa team for their tireless commitment to this effort. We will continue to devote significant resources to ensure that our regulatory compliance meets current standards worldwide with respect to our business."